Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B-PAD study).

Authors :: Nakahara T
Izuhara K
Onozuka D
Saeki H
Nunomura S
Takenaka M
Matsumoto M
Kataoka Y
Fujimoto R
Kaneko S
Morita E
Tanaka A
Hide M
Okano T
Miyagaki T
Aoki N
Nakajima K
Ichiyama S
Kido-Nakahara M
Tonomura K
Nakagawa Y
Tamagawa-Mineoka R
Masuda K
Takeichi T
Akiyama M
Ishiuji Y
Katsuta M
Kinoshita Y
Tateishi C
Yamamoto A
Morita A
Matsuda-Hirose H
Hatano Y
Kawasaki H
Tanese K
Ohtsuki M
Kamiya K
Kabata Y
Abe R
Mitsui H
Kawamura T
Tsuji G
Katoh N
Furue M
Source :: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2023 Feb; Vol. 53 (2), pp. 233-238. Date of Electronic Publication: 2022 Dec 16.
Publication Year :: 2023

Subjects :: Humans
Antibodies, Monoclonal, Humanized adverse effects
Antibodies, Monoclonal therapeutic use
Biomarkers
Treatment Outcome
Severity of Illness Index
Dermatitis, Atopic drug therapy
Dermatitis, Atopic chemically induced

Language :: English
ISSN :: 1365-2222
Volume :: 53
Issue :: 2
Database :: MEDLINE
Journal :: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Publication Type :: Report
Accession number :: 36524532
Full Text :: https://doi.org/10.1111/cea.14267

Full Text Access

Tools